Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,709 public trials 1,044 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Completed

A Study of PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

NCT02900664

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Breast Diseases, +31 more
Locations
  • Sidney Kimmel Comprehensive Cancer Center SC-3 Baltimore, Maryland, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 23 locations
View Trial Details
Completed

Phase 2 Study of Study of Tesevatinib in Subjects With NSCLC and Brain or Leptomeningeal Metastases

NCT02616393

Conditions
Brain Diseases, Brain Metastases, Brain Neoplasms, +18 more
Locations
  • Beverly Hills Cancer Center Beverly Hills, California, United States
  • USC Norris Oncology/Hematology Newport Beach Newport Beach, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View Trial Details
Completed

MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC

NCT04633564

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Grodno Clinical Regional Hospital Grodno, Hrodzenskaya Voblasts, Belarus
  • Mogilev Regional Oncology Dispensary Minsk, Minsk Oblast, Belarus
  • Babruysk Interregional Oncological Dispensary Babruysk, Belarus
  • State Institution NN Alexandrov Republican Scientific and Practical Centre of Oncology And Medical R Minsk, Belarus
View all 102 locations
View Trial Details
Completed

Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer

NCT01061840

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +21 more
Locations
  • Florida Cancer Specialists West Palm Beach, Florida, United States
  • Dartmouth-Hitchcock Medical Center/ Norris Cotton Cancer Center Lebanon, New Hampshire, United States
  • Mary Crowley Cancer Research Centers Dallas, Texas, United States
  • Cancer Care Northwest Spokane, Washington, United States
View Trial Details
Completed

Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)

NCT01059188

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +13 more
Locations
  • Saint Claraspital AG Basel, Switzerland
  • Universitaetsspital-Basel Basel, Switzerland
  • Istituto Oncologico della Svizzera Italiana - Ospedale San Giovanni Bellinzona, Switzerland
  • Inselspital Bern Bern, Switzerland
View all 15 locations
View Trial Details
Completed

Sorafenib/Erlotinib Versus Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)

NCT00600015

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Wellstar Cancer Research Marietta, Georgia, United States
  • Kansas City Cancer Centers Overland Park, Kansas, United States
View all 16 locations
View Trial Details
Completed

Evaluation of FKB238 and Avastin in Patients With Advanced/Recurrent Non-squamous Non-small Cell Lung Cancer

NCT02810457

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site 7814 - Compassionate Care Research Group Fountain Valley, California, United States
  • Research Site 7811 - Innovative Clinical Research Institute Whittier, California, United States
  • Research Site 7803 - 21st Century Oncology Jacksonville, Florida, United States
  • Research Site 7812 - Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View all 147 locations
View Trial Details
Completed

Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers

NCT02526017

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumors, +47 more
Locations
  • Scottsdale Healthcare Hospitals DBA Honor Health Scottsdale, Arizona, United States
  • Moores UC San Diego Cancer Center La Jolla, California, United States
  • Norris Comprehensive Cancer Center, University of Southern California Los Angeles, California, United States
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Center Los Angeles, California, United States
View all 39 locations
View Trial Details

Related conditions